Explain this page
Arphra AIPlain-English read on IDEXX Laboratories, Inc.’s valuationCompany profile
DB · companies + sec_company_profileIDEXX Laboratories, Inc. (IDXX) — the SEC company profile (description, website, HQ) has not been loaded for this ticker yet. Run the SEC profile loader to populate it.
AI description
Arphra AILoading cached description…
Identifiers
- SymbolIDXX
- Legal nameIDEXX Laboratories, Inc.
- SectorHealthcare
- IndustryMedical - Diagnostics & Research
- CountryUS
- CurrencyUSD
- ExchangeNASDAQ
- CIK0000874716
- ISIN—
- CUSIP—
- LEI—
- Employees—
Trading
DB · key_metrics_ttmMay 02, 2026- Market cap$45.18B
- P/E (TTM)—
- P/B—
- EV / EBITDA—
- Dividend yield—
Identifiers
OpenFIGI · GLEIFCross-source keys used to bridge market-data, SEC, and non-US sources.
- FIGIBBG000BLRT07
- CountryUSA
Key executives
DB · executives| Name | Title | Compensation | Born | Since |
|---|---|---|---|---|
| Jonathan J. Mazelsky | President, Chief Executive Officer & Director | $3.78M | 1961 | — |
| Michael J. Lane | Executive Vice President and GM Global Reference Laboratories, Diagnostic Solutions & Information Technology | $1.32M | 1968 | — |
| Nimrata Khatra Hunt | Advisor | $1.25M | 1968 | — |
| Martin Smith | Executive Vice President of Global Operations and R&D | $1.24M | 1968 | — |
| Andrew Emerson | Executive Vice President, Chief Financial Officer & Treasurer | $1.13M | 1983 | — |
| Sharon E. Underberg | Executive Vice President, General Counsel, & Corporate Secretary | $881.05K | 1961 | — |
| Julie Godon | Senior Vice President & Global Marketing Officer | — | — | — |
| Jeffery D. Chadbourne | Senior Vice President of Commercial Finance & Sales Operations | — | 1976 | — |